Clinical Trials Browser

Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Disease Progression, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05712356 2025-06-06

BOLSTER

Phase 2 Active not recruiting

67 enrolled

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Disease Progression

NCT02766699 2025-06-03

CerebralEDV

Phase 1 Completed

9 enrolled

CNS

Brain Neoplasms, Glioblastoma, Neoplasms, Neoplasms by Site, Recurrence, Disease Progression

NCT04503265 2025-05-01

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Phase 1/2 Recruiting

122 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Disease Progression

NCT02392078 2025-04-24

LAANTERN

Completed

1,153 enrolled 15 charts

CNS

Brain Neoplasms, Epilepsy, Movement Disorders, Disease Progression

Clinical Trials

TATE-PD1

ROTOR

CAPItrue

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

Carolyn-USA

RegisterNET

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice

Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL

BOLSTER

CerebralEDV

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

LAANTERN